{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alkaloids", "Cancer treatment", "Drug discovery", "Flavonoids", "Lung cancer", "PI3K/Akt/mTOR"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36721812", "DateRevised": {"Year": "2023", "Month": "02", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.34172/apb.2023.003"], "Journal": {"ISSN": "2228-5881", "JournalIssue": {"Volume": "13", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jan"}}, "Title": "Advanced pharmaceutical bulletin", "ISOAbbreviation": "Adv Pharm Bull"}, "ArticleTitle": "Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy.", "Pagination": {"StartPage": "24", "EndPage": "35", "MedlinePgn": "24-35"}, "Abstract": {"AbstractText": ["One of the central signaling pathways with a regulatory effect on cell proliferation and survival is Akt/mTOR. In many human cancer types, for instance, lung cancer, the overexpression of Akt/mTOR has been reported. For this reason, either targeting cancer cells by synthetic or natural products affecting the Akt/mTOR pathway down-regulation is a useful strategy in cancer therapy. Direct inhibition of the signaling pathway or modulation of each related molecule could have significant feedback on the growth and proliferation of cancer cells. A variety of secondary metabolites has been identified to directly inhibit the AKT/mTOR signaling, which is important in the field of drug discovery. Naturally occurring nitrogenous and phenolic compounds can emerge as two pivotal classes of natural products possessing anticancer abilities. Herein, we have summarized the alkaloids and flavonoids for lung cancer treatment together with all the possible mechanisms of action relying on the Akt/mTOR pathway down-regulation. This review suggested that in search of new drugs, phytochemicals could be considered as promising scaffolds to be developed into efficient drugs for the treatment of cancer. In this review, the terms \"Akt/mTOR\", \"Alkaloid\", \"flavonoid\", and \"lung cancer\" were searched without any limitation in search criteria in Scopus, PubMed, Web of Science, and Google scholar engines."], "CopyrightInformation": "\u00a92023 The Authors."}, "AuthorList": [{"Identifier": ["0000-0002-1492-1252"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran."}], "LastName": "Ghareghomi", "ForeName": "Somayyeh", "Initials": "S"}, {"Identifier": ["0000-0003-0292-0487"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Pharmaceutical Biotechnology, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran."}], "LastName": "Atabaki", "ForeName": "Vahideh", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurophysiology Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran."}], "LastName": "Abdollahzadeh", "ForeName": "Naseh", "Initials": "N"}, {"Identifier": ["0000-0002-3436-465X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran."}], "LastName": "Ahmadian", "ForeName": "Shahin", "Initials": "S"}, {"Identifier": ["0000-0001-5495-5556"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran."}], "LastName": "Hafez Ghoran", "ForeName": "Salar", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Adv Pharm Bull", "NlmUniqueID": "101578021", "ISSNLinking": "2228-5881"}, "CoiStatement": "The authors declare no potential competing interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386. doi: 10.1002/ijc.29210.", "ArticleIdList": ["10.1002/ijc.29210", "25220842"]}, {"Citation": "Thomas A, Liu SV, Subramaniam DS, Giaccone G. Refining the treatment of NSCLC according to histological and molecular subtypes. Nat Rev Clin Oncol. 2015;12(9):511\u201326. doi: 10.1038/nrclinonc.2015.90.", "ArticleIdList": ["10.1038/nrclinonc.2015.90", "25963091"]}, {"Citation": "Iacono D, Chiari R, Metro G, Bennati C, Bellezza G, Cenci M, et al. Future options for ALK-positive non-small cell lung cancer. Lung Cancer. 2015;87(3):211\u20139. doi: 10.1016/j.lungcan.2014.12.017.", "ArticleIdList": ["10.1016/j.lungcan.2014.12.017", "25601484"]}, {"Citation": "Rahmati-Yamchi M, Ghareghomi S, Haddadchi G, Milani M, Aghazadeh M, Daroushnejad H. Fenugreek extract diosgenin and pure diosgenin inhibit the hTERT gene expression in A549 lung cancer cell line. Mol Biol Rep. 2014;41(9):6247\u201352. doi: 10.1007/s11033-014-3505-y.", "ArticleIdList": ["10.1007/s11033-014-3505-y", "24973886"]}, {"Citation": "Rahmati-Yamchi M, Ghareghomi S, Haddadchi G, Mobasseri M, Rasmi Y. Diosgenin inhibits hTERT gene expression in the A549 lung cancer cell line. Asian Pac J Cancer Prev. 2013;14(11):6945\u20138. doi: 10.7314/apjcp.2013.14.11.6945.", "ArticleIdList": ["10.7314/apjcp.2013.14.11.6945", "24377630"]}, {"Citation": "Gonzalez E, McGraw TE. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle. 2009;8(16):2502\u20138. doi: 10.4161/cc.8.16.9335.", "ArticleIdList": ["10.4161/cc.8.16.9335", "PMC2997486", "19597332"]}, {"Citation": "Ruggero D, Sonenberg N. The Akt of translational control. Oncogene. 2005;24(50):7426\u201334. doi: 10.1038/sj.onc.1209098.", "ArticleIdList": ["10.1038/sj.onc.1209098", "16288289"]}, {"Citation": "Kizilboga T, Baskale EA, Yildiz J, Akcay IM, Zemheri E, Can ND, et al. Bag-1 stimulates Bad phosphorylation through activation of Akt and Raf kinases to mediate cell survival in breast cancer. BMC Cancer. 2019;19(1):1254. doi: 10.1186/s12885-019-6477-4.", "ArticleIdList": ["10.1186/s12885-019-6477-4", "PMC6935482", "31883527"]}, {"Citation": "Serrano BP, Hardy JA. Phosphorylation by protein kinase A disassembles the caspase-9 core. Cell Death Differ. 2018;25(6):1025\u201339. doi: 10.1038/s41418-017-0052-9.", "ArticleIdList": ["10.1038/s41418-017-0052-9", "PMC5988757", "29352269"]}, {"Citation": "George VC, Dellaire G, Rupasinghe HPV. Plant flavonoids in cancer chemoprevention: role in genome stability. J NutrBiochem. 2017;45:1\u201314. doi: 10.1016/j.jnutbio.2016.11.007.", "ArticleIdList": ["10.1016/j.jnutbio.2016.11.007", "27951449"]}, {"Citation": "Liskova A, Koklesova L, Samec M, Smejkal K, Samuel SM, Varghese E, et al. Flavonoids in Cancer Metastasis. Cancers (Basel) 2020;12(6):1498. doi: 10.3390/cancers12061498.", "ArticleIdList": ["10.3390/cancers12061498", "PMC7352928", "32521759"]}, {"Citation": "Zanoaga O, Braicu C, Jurj A, Rusu A, Buiga R, Berindan-Neagoe I. Progress in research on the role of flavonoids in lung cancer. Int J Mol Sci. 2019;20(17):4291. doi: 10.3390/ijms20174291.", "ArticleIdList": ["10.3390/ijms20174291", "PMC6747533", "31480720"]}, {"Citation": "Mondal A, Gandhi A, Fimognari C, Atanasov AG, Bishayee A. Alkaloids for cancer prevention and therapy: current progress and future perspectives. Eur J Pharmacol. 2019;858:172472. doi: 10.1016/j.ejphar.2019.172472.", "ArticleIdList": ["10.1016/j.ejphar.2019.172472", "31228447"]}, {"Citation": "Khattak S, Khan H. Anti-cancer potential of phyto-alkaloids: a prospective review. Curr Cancer Ther Rev. 2016;12(1):66\u201375. doi: 10.2174/1573394712666160617081638.", "ArticleIdList": ["10.2174/1573394712666160617081638"]}, {"Citation": "Ha\u0142as-Wi\u015bniewska M, Zieli\u0144ska W, Izdebska M, Grzanka A. The synergistic effect of piperlongumine and sanguinarine on the non-small lung cancer. Molecules. 2020;25(13):3045. doi: 10.3390/molecules25133045.", "ArticleIdList": ["10.3390/molecules25133045", "PMC7411589", "32635287"]}, {"Citation": "Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonz\u00e1les-Larriba JL, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7(9):719\u201327. doi: 10.1016/s1470-2045(06)70804-x.", "ArticleIdList": ["10.1016/s1470-2045(06)70804-x", "16945766"]}, {"Citation": "Paraskevopoulou MD, Tsichlis PN. A perspective on AKT 25-plus years after its discovery. Sci Signal. 2017;10(486):eaan8791. doi: 10.1126/scisignal.aan8791.", "ArticleIdList": ["10.1126/scisignal.aan8791", "28676491"]}, {"Citation": "Zhang D, Wang A, Feng J, Zhang Q, Liu L, Ren H. Ginsenoside Rg5 induces apoptosis in human esophageal cancer cells through the phosphoinositide-3 kinase/protein kinase B signaling pathway. Mol Med Rep. 2019;19(5):4019\u201326. doi: 10.3892/mmr.2019.10093.", "ArticleIdList": ["10.3892/mmr.2019.10093", "PMC6471319", "30942438"]}, {"Citation": "Le HT, Lee HJ, Cho J, Min HY, Lee JS, Lee SJ, et al. Insulin-like growth factor binding protein-3 exerts its anti-metastatic effect in aerodigestive tract cancers by disrupting the protein stability of vimentin. Cancers (Basel) 2021;13(5):1041. doi: 10.3390/cancers13051041.", "ArticleIdList": ["10.3390/cancers13051041", "PMC7958122", "33801272"]}, {"Citation": "Alzahrani AS. PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol. 2019;59:125\u201332. doi: 10.1016/j.semcancer.2019.07.009.", "ArticleIdList": ["10.1016/j.semcancer.2019.07.009", "31323288"]}, {"Citation": "Xu CX, Jin H, Shin JY, Kim JE, Cho MH. Roles of protein kinase B/Akt in lung cancer. Front Biosci (Elite Ed) 2010;2(4):1472\u201384. doi: 10.2741/e206.", "ArticleIdList": ["10.2741/e206", "20515818"]}, {"Citation": "Ghareghomi S, Ahmadian S, Zarghami N, Kahroba H. Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways. Biochimie. 2021;181:12\u201324. doi: 10.1016/j.biochi.2020.11.015.", "ArticleIdList": ["10.1016/j.biochi.2020.11.015", "33232793"]}, {"Citation": "Song M, Bode AM, Dong Z, Lee MH. AKT as a therapeutic target for cancer. Cancer Res. 2019;79(6):1019\u201331. doi: 10.1158/0008-5472.can-18-2738.", "ArticleIdList": ["10.1158/0008-5472.can-18-2738", "30808672"]}, {"Citation": "Hsiao YT, Fan MJ, Huang AC, Lien JC, Lin JJ, Chen JC, et al. Deguelin impairs cell adhesion, migration and invasion of human lung cancer cells through the NF-\u03ba B signaling pathways. Am J Chin Med. 2018;46(1):209\u201329. doi: 10.1142/s0192415x1850012x.", "ArticleIdList": ["10.1142/s0192415x1850012x", "29402127"]}, {"Citation": "Zheng X, Lu G, Yao Y, Gu W. An autocrine IL-6/IGF-1R loop mediates EMT and promotes tumor growth in non-small cell lung cancer. Int J Biol Sci. 2019;15(9):1882\u201391. doi: 10.7150/ijbs.31999.", "ArticleIdList": ["10.7150/ijbs.31999", "PMC6743301", "31523190"]}, {"Citation": "Padala RR, Karnawat R, Viswanathan SB, Thakkar AV, Das AB. Cancerous perturbations within the ERK, PI3K/Akt, and Wnt/\u03b2-catenin signaling network constitutively activate inter-pathway positive feedback loops. Mol Biosyst. 2017;13(5):830\u201340. doi: 10.1039/c6mb00786d.", "ArticleIdList": ["10.1039/c6mb00786d", "28367561"]}, {"Citation": "Wang Y, Xu C, Xu B, Li L, Li W, Wang W, et al. Xiaoai Jiedu Recipe inhibits proliferation and metastasis of non-small cell lung cancer cells by blocking the P38 mitogen-activated protein kinase (MAPK) pathway. Med Sci Monit. 2019;25:7538\u201346. doi: 10.12659/msm.917115.", "ArticleIdList": ["10.12659/msm.917115", "PMC6792514", "31590176"]}, {"Citation": "Malanga D, Scrima M, De Marco C, Fabiani F, De Rosa N, De Gisi S, et al. Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Cell Cycle. 2008;7(5):665\u20139. doi: 10.4161/cc.7.5.5485.", "ArticleIdList": ["10.4161/cc.7.5.5485", "18256540"]}, {"Citation": "Gridelli C, Maione P, Rossi A. The potential role of mTOR inhibitors in non-small cell lung cancer. Oncologist. 2008;13(2):139\u201347. doi: 10.1634/theoncologist.2007-0171.", "ArticleIdList": ["10.1634/theoncologist.2007-0171", "18305058"]}, {"Citation": "Du X, Qi F, Lu S, Li Y, Han W. Nicotine upregulates FGFR3 and RB1 expression and promotes non-small cell lung cancer cell proliferation and epithelial-to-mesenchymal transition via downregulation of miR-99b and miR-192. Biomed Pharmacother. 2018;101:656\u201362. doi: 10.1016/j.biopha.2018.02.113.", "ArticleIdList": ["10.1016/j.biopha.2018.02.113", "29518612"]}, {"Citation": "Merikallio H, Kaarteenaho R, Lind\u00e9n S, Padra M, Karimi R, Li CX, et al. Smoking-associated increase in mucins 1 and 4 in human airways. Respir Res. 2020;21(1):239. doi: 10.1186/s12931-020-01498-7.", "ArticleIdList": ["10.1186/s12931-020-01498-7", "PMC7499856", "32948202"]}, {"Citation": "An Z, Aksoy O, Zheng T, Fan QW, Weiss WA. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene. 2018;37(12):1561\u201375. doi: 10.1038/s41388-017-0045-7.", "ArticleIdList": ["10.1038/s41388-017-0045-7", "PMC5860944", "29321659"]}, {"Citation": "Inamura K, Ninomiya H, Ishikawa Y, Matsubara O. Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features? Arch Pathol Lab Med. 2010;134(1):66\u201372. doi: 10.5858/2008-0586-rar1.1.", "ArticleIdList": ["10.5858/2008-0586-rar1.1", "20073607"]}, {"Citation": "Memmott RM, Dennis PA. The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis. Clin Cancer Res. 2010;16(1):4\u201310. doi: 10.1158/1078-0432.ccr-09-0234.", "ArticleIdList": ["10.1158/1078-0432.ccr-09-0234", "PMC2805044", "20028747"]}, {"Citation": "Rom\u00e1n M, Baraibar I, L\u00f3pez I, Nadal E, Rolfo C, Vicent S, et al. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Mol Cancer. 2018;17(1):33. doi: 10.1186/s12943-018-0789-x.", "ArticleIdList": ["10.1186/s12943-018-0789-x", "PMC5817724", "29455666"]}, {"Citation": "Schuurbiers OC, Kaanders JH, van der Heijden HF, Dekhuijzen RP, Oyen WJ, Bussink J. The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer. J Thorac Oncol. 2009;4(6):761\u20137. doi: 10.1097/JTO.0b013e3181a1084f.", "ArticleIdList": ["10.1097/JTO.0b013e3181a1084f", "19404218"]}, {"Citation": "Perumal E, So Youn K, Sun S, Seung-Hyun J, Suji M, Jieying L, et al. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of \u03b2-catenin and snail/slug in non-small cell lung carcinoma cells. Lung Cancer. 2019;130:25\u201334. doi: 10.1016/j.lungcan.2019.01.013.", "ArticleIdList": ["10.1016/j.lungcan.2019.01.013", "30885348"]}, {"Citation": "Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC) Clin Chim Acta. 2010;411(11-12):846\u201352. doi: 10.1016/j.cca.2010.02.074.", "ArticleIdList": ["10.1016/j.cca.2010.02.074", "20223231"]}, {"Citation": "Mayoral RJ, Pipkin ME, Pachkov M, van Nimwegen E, Rao A, Monticelli S. MicroRNA-221-222 regulate the cell cycle in mast cells. J Immunol. 2009;182(1):433\u201345. doi: 10.4049/jimmunol.182.1.433.", "ArticleIdList": ["10.4049/jimmunol.182.1.433", "PMC2610349", "19109175"]}, {"Citation": "Lapthanasupkul P, Klongnoi B, Mutirangura A, Kitkumthorn N. Investigation of PTEN promoter methylation in ameloblastoma. Med Oral Patol Oral Cir Bucal. 2020;25(4):e481\u2013e7. doi: 10.4317/medoral.23498.", "ArticleIdList": ["10.4317/medoral.23498", "PMC7338066", "32134893"]}, {"Citation": "Montor WR, Salas A, Melo FHM. Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors. Mol Cancer. 2018;17(1):55. doi: 10.1186/s12943-018-0792-2.", "ArticleIdList": ["10.1186/s12943-018-0792-2", "PMC5817866", "29455659"]}, {"Citation": "Gibbons JJ, Abraham RT, Yu K. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth. Semin Oncol. 2009;36 Suppl 3:S3\u2013S17. doi: 10.1053/j.seminoncol.2009.10.011.", "ArticleIdList": ["10.1053/j.seminoncol.2009.10.011", "19963098"]}, {"Citation": "Li X, Wu C, Chen N, Gu H, Yen A, Cao L, et al. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7(22):33440\u201350. doi: 10.18632/oncotarget.7961.", "ArticleIdList": ["10.18632/oncotarget.7961", "PMC5078108", "26967052"]}, {"Citation": "Wang Z, Yang MQ, Lei L, Fei LR, Zheng YW, Huang WJ, et al. Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis. Cancer Manag Res. 2019;11:7485\u201397. doi: 10.2147/cmar.s218926.", "ArticleIdList": ["10.2147/cmar.s218926", "PMC6689799", "31496806"]}, {"Citation": "Mart\u00ednez-Garc\u00eda D, Manero-Rup\u00e9rez N, Quesada R, Korrodi-Greg\u00f3rio L, Soto-Cerrato V. Therapeutic strategies involving survivin inhibition in cancer. Med Res Rev. 2019;39(3):887\u2013909. doi: 10.1002/med.21547.", "ArticleIdList": ["10.1002/med.21547", "30421440"]}, {"Citation": "Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 2005;24(50):7410\u201325. doi: 10.1038/sj.onc.1209086.", "ArticleIdList": ["10.1038/sj.onc.1209086", "16288288"]}, {"Citation": "Liu Y, Ao X, Ding W, Ponnusamy M, Wu W, Hao X, et al. Critical role of FOXO3a in carcinogenesis. Mol Cancer. 2018;17(1):104. doi: 10.1186/s12943-018-0856-3.", "ArticleIdList": ["10.1186/s12943-018-0856-3", "PMC6060507", "30045773"]}, {"Citation": "Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985) 2000;88(4):1474\u201380. doi: 10.1152/jappl.2000.88.4.1474.", "ArticleIdList": ["10.1152/jappl.2000.88.4.1474", "10749844"]}, {"Citation": "Huang J, Gao L, Li B, Liu C, Hong S, Min J, et al. Knockdown of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) promotes autophagy and inhibits phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway in ovarian cancer cells. Med Sci Monit. 2019;25:4250\u201363. doi: 10.12659/msm.915730.", "ArticleIdList": ["10.12659/msm.915730", "PMC6573092", "31175269"]}, {"Citation": "Soni S, Padwad YS. HIF-1 in cancer therapy: two decade long story of a transcription factor. Acta Oncol. 2017;56(4):503\u201315. doi: 10.1080/0284186x.2017.1301680.", "ArticleIdList": ["10.1080/0284186x.2017.1301680", "28358664"]}, {"Citation": "Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res. 2009;102:19\u201365. doi: 10.1016/s0065-230x(09)02002-8.", "ArticleIdList": ["10.1016/s0065-230x(09)02002-8", "PMC2933405", "19595306"]}, {"Citation": "Wang H, Wang L, Cao L, Zhang Q, Song Q, Meng Z, et al. Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells. Mol Carcinog. 2018;57(4):522\u201335. doi: 10.1002/mc.22777.", "ArticleIdList": ["10.1002/mc.22777", "29278657"]}, {"Citation": "Li X, Wu JF. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs) Recent Pat Anticancer Drug Discov. 2010;5(2):109\u201341. doi: 10.2174/157489210790936234.", "ArticleIdList": ["10.2174/157489210790936234", "19951249"]}, {"Citation": "Rath B, Klameth L, Plangger A, Hochmair M, Ulsperger E, Huk I, et al. Expression of proteolytic enzymes by small cell lung cancer circulating tumor cell lines. Cancers (Basel) 2019;11(1):114. doi: 10.3390/cancers11010114.", "ArticleIdList": ["10.3390/cancers11010114", "PMC6357007", "30669448"]}, {"Citation": "Huang H. Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances. Sensors (Basel) 2018;18(10):3249. doi: 10.3390/s18103249.", "ArticleIdList": ["10.3390/s18103249", "PMC6211011", "30262739"]}, {"Citation": "Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. BiochimBiophys Acta. 2013;1830(6):3670\u201395. doi: 10.1016/j.bbagen.2013.02.008.", "ArticleIdList": ["10.1016/j.bbagen.2013.02.008", "PMC3672862", "23428572"]}, {"Citation": "Amararathna M, Johnston MR, Rupasinghe HP. Plant polyphenols as chemopreventive agents for lung cancer. Int J Mol Sci. 2016;17(8):1352. doi: 10.3390/ijms17081352.", "ArticleIdList": ["10.3390/ijms17081352", "PMC5000748", "27548149"]}, {"Citation": "Batra P, Sharma AK. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech. 2013;3(6):439\u201359. doi: 10.1007/s13205-013-0117-5.", "ArticleIdList": ["10.1007/s13205-013-0117-5", "PMC3824783", "28324424"]}, {"Citation": "Costea T, Vlad OC, Miclea LC, Ganea C, Sz\u00f6ll\u0151si J, Mocanu MM. Alleviation of multidrug resistance by flavonoid and non-flavonoid compounds in breast, lung, colorectal and prostate cancer. Int J Mol Sci. 2020;21(2):401. doi: 10.3390/ijms21020401.", "ArticleIdList": ["10.3390/ijms21020401", "PMC7013436", "31936346"]}, {"Citation": "Ballout F, Habli Z, Monzer A, Rahal ON, Fatfat M, Gali-Muhtasib H. Anticancer alkaloids: molecular mechanisms and clinical manifestations. In: Sharma AK, ed. Bioactive Natural Products for the Management of Cancer: From Bench to Bedside. Singapore: Springer; 2019. p. 1-35. 10.1007/978-981-13-7607-8_1.", "ArticleIdList": ["10.1007/978-981-13-7607-8_1"]}, {"Citation": "Xu WT, Li TZ, Li SM, Wang C, Wang H, Luo YH, et al. Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways. Artif Cells NanomedBiotechnol. 2020;48(1):84\u201395. doi: 10.1080/21691401.2019.1699813.", "ArticleIdList": ["10.1080/21691401.2019.1699813", "31852250"]}, {"Citation": "Niu H, Zhang Y, Wu B, Zhang Y, Jiang H, He P. Matrine induces the apoptosis of lung cancer cells through downregulation of inhibitor of apoptosis proteins and the Akt signaling pathway. Oncol Rep. 2014;32(3):1087\u201393. doi: 10.3892/or.2014.3273.", "ArticleIdList": ["10.3892/or.2014.3273", "24969052"]}, {"Citation": "Li W, Yu X, Tan S, Liu W, Zhou L, Liu H. Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway. Cancer Med. 2018;7(1):208\u201318. doi: 10.1002/cam4.1269.", "ArticleIdList": ["10.1002/cam4.1269", "PMC5773973", "29239135"]}, {"Citation": "Lin L, Ren L, Wen L, Wang Y, Qi J. Effect of evodiamine on the proliferation and apoptosis of A549 human lung cancer cells. Mol Med Rep. 2016;14(3):2832\u20138. doi: 10.3892/mmr.2016.5575.", "ArticleIdList": ["10.3892/mmr.2016.5575", "27485202"]}, {"Citation": "Mohan V, Agarwal R, Singh RP. A novel alkaloid, evodiamine causes nuclear localization of cytochrome-c and induces apoptosis independent of p53 in human lung cancer cells. BiochemBiophys Res Commun. 2016;477(4):1065\u201371. doi: 10.1016/j.bbrc.2016.07.037.", "ArticleIdList": ["10.1016/j.bbrc.2016.07.037", "27402273"]}, {"Citation": "Zhang R, Li G, Zhang Q, Tang Q, Huang J, Hu C, et al. Hirsutine induces mPTP-dependent apoptosis through ROCK1/PTEN/PI3K/GSK3\u03b2 pathway in human lung cancer cells. Cell Death Dis. 2018;9(6):598. doi: 10.1038/s41419-018-0641-7.", "ArticleIdList": ["10.1038/s41419-018-0641-7", "PMC5964100", "29789524"]}, {"Citation": "Ali A, Sidorova TS, Matesic DF. Dual modulation of JNK and Akt signaling pathways by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cells. Invest New Drugs. 2013;31(3):525\u201334. doi: 10.1007/s10637-012-9883-x.", "ArticleIdList": ["10.1007/s10637-012-9883-x", "PMC3915520", "23054210"]}, {"Citation": "Poornima P, Weng CF, Padma VV. Neferine from Nelumbo nucifera induces autophagy through the inhibition of PI3K/Akt/mTOR pathway and ROS hyper generation in A549 cells. Food Chem. 2013;141(4):3598\u2013605. doi: 10.1016/j.foodchem.2013.05.138.", "ArticleIdList": ["10.1016/j.foodchem.2013.05.138", "23993526"]}, {"Citation": "Sivalingam K, Amirthalingam V, Ganasan K, Huang CY, Viswanadha VP. Neferine suppresses diethylnitrosamine-induced lung carcinogenesis in Wistar rats. Food Chem Toxicol. 2019;123:385\u201398. doi: 10.1016/j.fct.2018.11.014.", "ArticleIdList": ["10.1016/j.fct.2018.11.014", "30423403"]}, {"Citation": "Kalai Selvi S, Vinoth A, Varadharajan T, Weng CF, Vijaya Padma V. Neferine augments therapeutic efficacy of cisplatin through ROS- mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells) Food Chem Toxicol. 2017;103:28\u201340. doi: 10.1016/j.fct.2017.02.020.", "ArticleIdList": ["10.1016/j.fct.2017.02.020", "28223119"]}, {"Citation": "Liu Z, Ma L, Wen ZS, Cheng YX, Zhou GB. Ethoxysanguinarine induces inhibitory effects and downregulates CIP2A in lung cancer cells. ACS Med Chem Lett. 2014;5(2):113\u20138. doi: 10.1021/ml400341k.", "ArticleIdList": ["10.1021/ml400341k", "PMC4027744", "24900782"]}, {"Citation": "Chougule M, Patel AR, Sachdeva P, Jackson T, Singh M. Anticancer activity of noscapine, an opioid alkaloid in combination with cisplatin in human non-small cell lung cancer. Lung Cancer. 2011;71(3):271\u201382. doi: 10.1016/j.lungcan.2010.06.002.", "ArticleIdList": ["10.1016/j.lungcan.2010.06.002", "PMC3094914", "20674069"]}, {"Citation": "Lai H, Wang Y, Duan F, Li Y, Jiang Z, Luo L, et al. Krukovine suppresses KRAS-mutated lung cancer cell growth and proliferation by inhibiting the RAF-ERK pathway and inactivating AKT pathway. Front Pharmacol. 2018;9:958. doi: 10.3389/fphar.2018.00958.", "ArticleIdList": ["10.3389/fphar.2018.00958", "PMC6113384", "30186180"]}, {"Citation": "Cho HS, Chang SH, Chung YS, Shin JY, Park SJ, Lee ES, et al. Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci. 2009;10(1):23\u20138. doi: 10.4142/jvs.2009.10.1.23.", "ArticleIdList": ["10.4142/jvs.2009.10.1.23", "PMC2801106", "19255520"]}, {"Citation": "Fu L, Chen W, Guo W, Wang J, Tian Y, Shi D, et al. Berberine targets AP-2/hTERT, NF-\u03baB/COX-2, HIF-1\u03b1/VEGF and cytochrome-c/caspase signaling to suppress human cancer cell growth. PLoS One. 2013;8(7):e69240. doi: 10.1371/journal.pone.0069240.", "ArticleIdList": ["10.1371/journal.pone.0069240", "PMC3711861", "23869238"]}, {"Citation": "Sirimangkalakitti N, Chamni S, Suwanborirux K, Chanvorachote P. Renieramycin M sensitizes anoikis-resistant H460 lung cancer cells to anoikis. Anticancer Res. 2016;36(4):1665\u201371.", "ArticleIdList": ["27069144"]}, {"Citation": "Shen KH, Hung JH, Chang CW, Weng YT, Wu MJ, Chen PS. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression. Chem Biol Interact. 2017;268:129\u201335. doi: 10.1016/j.cbi.2017.03.005.", "ArticleIdList": ["10.1016/j.cbi.2017.03.005", "28283413"]}, {"Citation": "Chatterjee P, Seal S, Mukherjee S, Kundu R, Bhuyan M, Barua NC, et al. A carbazole alkaloid deactivates mTOR through the suppression of rictor and that induces apoptosis in lung cancer cells. Mol Cell Biochem. 2015;405(1-2):149\u201358. doi: 10.1007/s11010-015-2406-2.", "ArticleIdList": ["10.1007/s11010-015-2406-2", "25893736"]}, {"Citation": "Wang F, Mao Y, You Q, Hua D, Cai D. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway. Int J ImmunopatholPharmacol. 2015;28(3):362\u201373. doi: 10.1177/0394632015598849.", "ArticleIdList": ["10.1177/0394632015598849", "26246196"]}, {"Citation": "Seok JS, Jeong CH, Petriello MC, Seo HG, Yoo H, Hong K, et al. Piperlongumine decreases cell proliferation and the expression of cell cycle-associated proteins by inhibiting Akt pathway in human lung cancer cells. Food Chem Toxicol. 2018;111:9\u201318. doi: 10.1016/j.fct.2017.10.058.", "ArticleIdList": ["10.1016/j.fct.2017.10.058", "29109039"]}, {"Citation": "Ooppachai C, Limtrakul Dejkriengkraikul P, Yodkeeree S. Dicentrine potentiates TNF-\u03b1-induced apoptosis and suppresses invasion of A549 lung adenocarcinoma cells via modulation of NF-\u03baB and AP-1 activation. Molecules. 2019;24(22):3100. doi: 10.3390/molecules24224100.", "ArticleIdList": ["10.3390/molecules24224100", "PMC6891634", "31766230"]}, {"Citation": "Chang HL, Chang YM, Lai SC, Chen KM, Wang KC, Chiu TT, et al. Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9. Exp Ther Med. 2017;13(2):739\u201344. doi: 10.3892/etm.2016.3994.", "ArticleIdList": ["10.3892/etm.2016.3994", "PMC5348669", "28352360"]}, {"Citation": "Moon JY, Manh Hung LV, Unno T, Cho SK. Nobiletin enhances chemosensitivity to adriamycin through modulation of the Akt/GSK3\u03b2/\u03b2-catenin /MYCN/MRP1 signaling pathway in A549 human non-small-cell lung cancer cells. Nutrients. 2018;10(12):1829. doi: 10.3390/nu10121829.", "ArticleIdList": ["10.3390/nu10121829", "PMC6316077", "30486290"]}, {"Citation": "Zhang Y, Zhang R, Ni H. Eriodictyol exerts potent anticancer activity against A549 human lung cancer cell line by inducing mitochondrial-mediated apoptosis, G2/M cell cycle arrest and inhibition of m-TOR/PI3K/Akt signalling pathway. Arch Med Sci. 2020;16(2):446\u201352. doi: 10.5114/aoms.2019.85152.", "ArticleIdList": ["10.5114/aoms.2019.85152", "PMC7069446", "32190156"]}, {"Citation": "Shao JJ, Zhang AP, Qin W, Zheng L, Zhu YF, Chen X. AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells. BiochemBiophys Res Commun. 2012;423(3):448\u201353. doi: 10.1016/j.bbrc.2012.05.123.", "ArticleIdList": ["10.1016/j.bbrc.2012.05.123", "22659738"]}, {"Citation": "Zhou Z, Tang M, Liu Y, Zhang Z, Lu R, Lu J. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line. Anticancer Drugs. 2017;28(4):446\u201356. doi: 10.1097/cad.0000000000000479.", "ArticleIdList": ["10.1097/cad.0000000000000479", "28125432"]}, {"Citation": "Chen M, Wang X, Zha D, Cai F, Zhang W, He Y, et al. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner. Sci Rep. 2016;6:35468. doi: 10.1038/srep35468.", "ArticleIdList": ["10.1038/srep35468", "PMC5067669", "27752089"]}, {"Citation": "Chang JH, Cheng CW, Yang YC, Chen WS, Hung WY, Chow JM, et al. Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses. J Exp Clin Cancer Res. 2018;37(1):199. doi: 10.1186/s13046-018-0869-1.", "ArticleIdList": ["10.1186/s13046-018-0869-1", "PMC6104010", "30134935"]}, {"Citation": "Yu M, Qi B, Xiaoxiang W, Xu J, Liu X. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-\u03baB pathway. Biomed Pharmacother. 2017;90:677\u201385. doi: 10.1016/j.biopha.2017.04.001.", "ArticleIdList": ["10.1016/j.biopha.2017.04.001", "28415048"]}, {"Citation": "Chen KC, Chen CY, Lin CR, Yang TY, Chen TH, Wu LC, et al. Luteolin attenuates TGF-\u03b21-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-\u03baB-Snail pathway. Life Sci. 2013;93(24):924\u201333. doi: 10.1016/j.lfs.2013.10.004.", "ArticleIdList": ["10.1016/j.lfs.2013.10.004", "24140887"]}, {"Citation": "Khan N, Afaq F, Khusro FH, Mustafa Adhami V, Suh Y, Mukhtar H. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin. Int J Cancer. 2012;130(7):1695\u2013705. doi: 10.1002/ijc.26178.", "ArticleIdList": ["10.1002/ijc.26178", "PMC3267899", "21618507"]}, {"Citation": "Han X, Liu CF, Gao N, Zhao J, Xu J. Kaempferol suppresses proliferation but increases apoptosis and autophagy by up-regulating microRNA-340 in human lung cancer cells. Biomed Pharmacother. 2018;108:809\u201316. doi: 10.1016/j.biopha.2018.09.087.", "ArticleIdList": ["10.1016/j.biopha.2018.09.087", "30253373"]}, {"Citation": "Nguyen TT, Tran E, Ong CK, Lee SK, Do PT, Huynh TT, et al. Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol. 2003;197(1):110\u201321. doi: 10.1002/jcp.10340.", "ArticleIdList": ["10.1002/jcp.10340", "12942547"]}, {"Citation": "Chang JH, Lai SL, Chen WS, Hung WY, Chow JM, Hsiao M, et al. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways. BiochimBiophys Acta Mol Cell Res. 2017;1864(10):1746\u201358. doi: 10.1016/j.bbamcr.2017.06.017.", "ArticleIdList": ["10.1016/j.bbamcr.2017.06.017", "28648644"]}, {"Citation": "Chen W, Wang X, Zhuang J, Zhang L, Lin Y. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis. 2007;28(10):2114\u201321. doi: 10.1093/carcin/bgm133.", "ArticleIdList": ["10.1093/carcin/bgm133", "17548900"]}, {"Citation": "Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004;25(5):647\u201359. doi: 10.1093/carcin/bgh052.", "ArticleIdList": ["10.1093/carcin/bgh052", "14688022"]}, {"Citation": "Yeh SL, Yeh CL, Chan ST, Chuang CH. Plasma rich in quercetin metabolites induces G2/M arrest by upregulating PPAR-\u03b3 expression in human A549 lung cancer cells. Planta Med. 2011;77(10):992\u20138. doi: 10.1055/s-0030-1250735.", "ArticleIdList": ["10.1055/s-0030-1250735", "21267808"]}, {"Citation": "Chen KH, Weng MS, Lin JK. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. BiochemPharmacol. 2007;73(2):215\u201327. doi: 10.1016/j.bcp.2006.09.018.", "ArticleIdList": ["10.1016/j.bcp.2006.09.018", "17067555"]}, {"Citation": "Tsai MH, Liu JF, Chiang YC, Hu SC, Hsu LF, Lin YC, et al. Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells. Oncotarget. 2017;8(17):28342\u201358. doi: 10.18632/oncotarget.16058.", "ArticleIdList": ["10.18632/oncotarget.16058", "PMC5438654", "28423703"]}, {"Citation": "Chen H, Yang J, Hao J, Lv Y, Chen L, Lin Q, et al. A novel flavonoid kushenol Z from Sophora flavescens mediates mTOR pathway by inhibiting phosphodiesterase and Akt activity to induce apoptosis in non-small-cell lung cancer cells. Molecules. 2019;24(24):4425. doi: 10.3390/molecules24244425.", "ArticleIdList": ["10.3390/molecules24244425", "PMC6943755", "31817093"]}, {"Citation": "Tsai YM, Yang CJ, Hsu YL, Wu LY, Tsai YC, Hung JY, et al. Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/rho signaling pathway. Integr Cancer Ther. 2011;10(4):341\u20139. doi: 10.1177/1534735410384860.", "ArticleIdList": ["10.1177/1534735410384860", "21059620"]}, {"Citation": "Wang S, Yan Y, Cheng Z, Hu Y, Liu T. Sotetsuflavone suppresses invasion and metastasis in non-small-cell lung cancer A549 cells by reversing EMT via the TNF-\u03b1/NF-\u03baB and PI3K/AKT signaling pathway. Cell Death Discov. 2018;4:26. doi: 10.1038/s41420-018-0026-9.", "ArticleIdList": ["10.1038/s41420-018-0026-9", "PMC5841291", "29531823"]}, {"Citation": "Liu X, Jiang Q, Liu H, Luo S. Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells. Biol Res. 2019;52(1):7. doi: 10.1186/s40659-019-0214-y.", "ArticleIdList": ["10.1186/s40659-019-0214-y", "PMC6387544", "30797236"]}, {"Citation": "Zhou M, Shen S, Zhao X, Gong X. Luteoloside induces G0/G1 arrest and pro-death autophagy through the ROS-mediated AKT/mTOR/p70S6K signalling pathway in human non-small cell lung cancer cell lines. BiochemBiophys Res Commun. 2017;494(1-2):263\u20139. doi: 10.1016/j.bbrc.2017.10.042.", "ArticleIdList": ["10.1016/j.bbrc.2017.10.042", "29024631"]}, {"Citation": "Luo Y, Ren Z, Du B, Xing S, Huang S, Li Y, et al. Structure identification of viceninii extracted from Dendrobium officinale and the reversal of TGF-\u03b21-induced epithelial\u207bmesenchymal transition in lung adenocarcinoma cells through TGF-\u03b2/Smad and PI3K/Akt/mTOR signaling pathways. Molecules. 2019;24(1):144. doi: 10.3390/molecules24010144.", "ArticleIdList": ["10.3390/molecules24010144", "PMC6337427", "30609689"]}, {"Citation": "Baruah TJ, Kma L. Vicenin-2 acts as a radiosensitizer of the non-small cell lung cancer by lowering Akt expression. Biofactors. 2019;45(2):200\u201310. doi: 10.1002/biof.1472.", "ArticleIdList": ["10.1002/biof.1472", "30496626"]}, {"Citation": "Chen M, Cai F, Zha D, Wang X, Zhang W, He Y, et al. Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-\u043aB pathway. Oncotarget. 2017;8(16):26941\u201358. doi: 10.18632/oncotarget.15264.", "ArticleIdList": ["10.18632/oncotarget.15264", "PMC5432309", "28199969"]}, {"Citation": "Lago JH, Toledo-Arruda AC, Mernak M, Barrosa KH, Martins MA, Tib\u00e9rio IF, et al. Structure-activity association of flavonoids in lung diseases. Molecules. 2014;19(3):3570\u201395. doi: 10.3390/molecules19033570.", "ArticleIdList": ["10.3390/molecules19033570", "PMC6271797", "24662074"]}, {"Citation": "Amawi H, Ashby CR Jr, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what\u2019s limiting? Chin J Cancer. 2017;36(1):50. doi: 10.1186/s40880-017-0217-4.", "ArticleIdList": ["10.1186/s40880-017-0217-4", "PMC5477375", "28629389"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "4"}, {"Year": "2021", "Month": "7", "Day": "27"}, {"Year": "2021", "Month": "9", "Day": "28"}, {"Year": "2023", "Month": "2", "Day": "1", "Hour": "1", "Minute": "51"}, {"Year": "2023", "Month": "2", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "2", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "10", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36721812", "PMC9871280", "10.34172/apb.2023.003"]}}], "PubmedBookArticle": []}